SCM
NNVC icon

Segantii Capital Management’s NanoViricides NNVC Stock Holding History

Segantii Capital Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,540
Closed -$183K – 88
2016
Q1 		$183K Buy
+3,540
New +$137K 0.08% 96

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Segantii Capital Management's NNVC Position: Q2 2016 in Review

Segantii Capital Management sold out of NanoViricides (NNVC) in Q2 2016, closing a stake of 3,540 shares — an estimated $183K sold.

Segantii Capital Management first reported a position in NNVC in Q1 2016 and held it in 1 quarter. The position peaked at $183K in Q1 2016. 51 funds tracked by Wall St. Rank hold NNVC as of Q2 2016.

  • Segantii Capital Management reported no remaining NanoViricides position as of Q2 2016 after selling out during the quarter.
  • Segantii Capital Management sold 3,540 NanoViricides shares in Q2 2016, an estimated $183K.
  • Segantii Capital Management first reported a position in NanoViricides in Q1 2016 and held it in 1 quarter.
  • Segantii Capital Management's NanoViricides position peaked at $183K in Q1 2016.
  • 51 funds tracked by Wall St. Rank held NanoViricides as of Q2 2016.

Based on Segantii Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.